Taking these findings together, the activation of p53 by the combination treatment specifically in p53 wild type NSCLC cells resulted in the disruption of pyrimidine nucleotide synthesis, which induced replication stress and DNA damage as stimulators of apoptosis. Here, TP53 is linked to non-small cell lung carcinoma.